These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 10775795)
1. Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. Maassen CB; van Holten-Neelen C; Balk F; den Bak-Glashouwer MJ; Leer RJ; Laman JD; Boersma WJ; Claassen E Vaccine; 2000 May; 18(23):2613-23. PubMed ID: 10775795 [TBL] [Abstract][Full Text] [Related]
2. Well-controlled proinflammatory cytokine responses of Peyer's patch cells to probiotic Lactobacillus casei. Chiba Y; Shida K; Nagata S; Wada M; Bian L; Wang C; Shimizu T; Yamashiro Y; Kiyoshima-Shibata J; Nanno M; Nomoto K Immunology; 2010 Jul; 130(3):352-62. PubMed ID: 20636824 [TBL] [Abstract][Full Text] [Related]
3. Interaction of lactic acid bacteria with the gut immune system. Perdigón G; Maldonado Galdeano C; Valdez JC; Medici M Eur J Clin Nutr; 2002 Dec; 56 Suppl 4():S21-6. PubMed ID: 12556943 [TBL] [Abstract][Full Text] [Related]
4. Orally administered Lactobacillus strains differentially affect the direction and efficacy of the immune response. Maassen CB; van Holten JC; Balk F; Heijne den Bak-Glashouwer MJ; Leer R; Laman JD; Boersma WJ; Claassen E Vet Q; 1998; 20 Suppl 3():S81-3. PubMed ID: 9689733 [TBL] [Abstract][Full Text] [Related]
5. Impaired mucosal immune responses in interleukin 4-targeted mice. Vajdy M; Kosco-Vilbois MH; Kopf M; Köhler G; Lycke N J Exp Med; 1995 Jan; 181(1):41-53. PubMed ID: 7807021 [TBL] [Abstract][Full Text] [Related]
6. The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity. Galdeano CM; Perdigón G Clin Vaccine Immunol; 2006 Feb; 13(2):219-26. PubMed ID: 16467329 [TBL] [Abstract][Full Text] [Related]
7. Oral vaccine models: multiple delivery systems employing tetanus toxoid. Jackson RJ; Staats HF; Xu-Amano J; Takahashi I; Kiyono H; Hudson ME; Gilley RM; Chatfield SN; McGhee JR Ann N Y Acad Sci; 1994 Aug; 730():217-34. PubMed ID: 8080173 [TBL] [Abstract][Full Text] [Related]
8. Effect of the administration of Lactobacillus paracasei subsp. paracasei NTU 101 on Peyer's patch-mediated mucosal immunity. Tsai YT; Cheng PC; Liao JW; Pan TM Int Immunopharmacol; 2010 Jul; 10(7):791-8. PubMed ID: 20417727 [TBL] [Abstract][Full Text] [Related]
9. Recombinant interleukin 6 with M cell-targeting moiety produced in Lactococcus lactis IL1403 as a potent mucosal adjuvant for peroral immunization. Li HS; Piao DC; Jiang T; Bok JD; Cho CS; Lee YS; Kang SK; Choi YJ Vaccine; 2015 Apr; 33(16):1959-67. PubMed ID: 25738814 [TBL] [Abstract][Full Text] [Related]
10. Spectrum of gut immunologic reactions: selective induction of distinct responses to Vibrio cholerae WO7 and its toxin. Walia K; Vohra H; Singh H; Ganguly NK Microbiol Immunol; 2000; 44(11):931-40. PubMed ID: 11145274 [TBL] [Abstract][Full Text] [Related]
11. Adjuvant effects for oral immunization provided by recombinant Lactobacillus casei secreting biologically active murine interleukin-1{beta}. Kajikawa A; Masuda K; Katoh M; Igimi S Clin Vaccine Immunol; 2010 Jan; 17(1):43-8. PubMed ID: 19923575 [TBL] [Abstract][Full Text] [Related]
12. Relationship between the in vitro response of dendritic cells to Lactobacillus and prevention of tumorigenesis in the mouse. Takagi A; Ikemura H; Matsuzaki T; Sato M; Nomoto K; Morotomi M; Yokokura T J Gastroenterol; 2008; 43(9):661-9. PubMed ID: 18807127 [TBL] [Abstract][Full Text] [Related]
13. Growth phase of orally administered Lactobacillus strains differentially affects IgG1/IgG2a ratio for soluble antigens: implications for vaccine development. Maassen CB; Boersma WJ; van Holten-Neelen C; Claassen E; Laman JD Vaccine; 2003 Jun; 21(21-22):2751-7. PubMed ID: 12798614 [TBL] [Abstract][Full Text] [Related]
14. Effect of oral administration of heat-killed Lactobacillus brevis SBC8803 on total and ovalbumin-specific immunoglobulin E production through the improvement of Th1/Th2 balance. Segawa S; Nakakita Y; Takata Y; Wakita Y; Kaneko T; Kaneda H; Watari J; Yasui H Int J Food Microbiol; 2008 Jan; 121(1):1-10. PubMed ID: 18055049 [TBL] [Abstract][Full Text] [Related]
15. An intra-Peyer's patch gene transfer model for studying mucosal tolerance: distinct roles of B7 and IL-12 in mucosal T cell tolerance. Chen Y; Song K; Eck SL J Immunol; 2000 Sep; 165(6):3145-53. PubMed ID: 10975828 [TBL] [Abstract][Full Text] [Related]
16. Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance. Neurath MF; Fuss I; Kelsall BL; Presky DH; Waegell W; Strober W J Exp Med; 1996 Jun; 183(6):2605-16. PubMed ID: 8676081 [TBL] [Abstract][Full Text] [Related]
17. Induction of gut mucosal immune responses: importance of genetic background and Th1/Th2 cross-regulation. Kjerrulf M; Grdic D; Kopf M; Lycke N Scand J Immunol; 1998 May; 47(5):401-7. PubMed ID: 9627122 [TBL] [Abstract][Full Text] [Related]
18. Comparative study of the protective capacity against Salmonella infection between probiotic and nonprobiotic Lactobacilli. Castillo NA; de Moreno de LeBlanc A; M Galdeano C; Perdigón G J Appl Microbiol; 2013 Mar; 114(3):861-76. PubMed ID: 23163296 [TBL] [Abstract][Full Text] [Related]
19. Antigen-specific, CD4+CD25+ regulatory T cell clones induced in Peyer's patches. Tsuji NM; Mizumachi K; Kurisaki J Int Immunol; 2003 Apr; 15(4):525-34. PubMed ID: 12663682 [TBL] [Abstract][Full Text] [Related]
20. Relationship between interaction sites in the gut, hydrophobicity, mucosal immunomodulating capacities and cell wall protein profiles in indigenous and exogenous bacteria. Vinderola CG; Medici M; Perdigón G J Appl Microbiol; 2004; 96(2):230-43. PubMed ID: 14723684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]